Neurogenic Bladder and Detrusor Muscle Insufficiency Guidelines

Definition and Diagnosis

Neurogenic bladder refers to abnormal function of the bladder, bladder neck, and/or sphincters specifically related to a neurologic disorder, with symptoms including urinary incontinence, retention, recurrent UTIs, and in some cases autonomic dysreflexia, according to the American Urological Association 1, 2
Detrusor underactivity is defined by reduced strength and/or duration of detrusor contraction, resulting in prolonged or incomplete bladder emptying, with symptoms including weak urinary stream 3, straining to void 4, and incomplete emptying 4

Neurogenic bladder always has an underlying neurological disorder, such as multiple sclerosis 5, cerebrovascular accidents (stroke) 6, or Parkinson's disease 6, as stated by the European Association of Urology 1, 2
Detrusor underactivity can be neurogenic or non-neurogenic (myogenic, idiopathic, aging-related) 4

Neurogenic bladder requires comprehensive neurological assessment and urodynamic studies, as recommended by the International Continence Society 7
Detrusor underactivity diagnosis primarily involves pressure-flow studies to demonstrate reduced detrusor contractility 4

Neurogenic bladder treatment focuses on risk stratification and preventing upper urinary tract damage, with options including anticholinergics, beta-3 agonists, and intermittent catheterization, according to the American Urological Association 1, 3, 2
Detrusor underactivity treatment focuses on facilitating bladder emptying, with options including timed voiding, double voiding, and sometimes catheterization, as suggested by the European Association of Urology 4

Risk stratification is essential to prevent upper tract damage in neurogenic bladder patients, as emphasized by the International Continence Society 7
Complex cystometrogram (CMG) is recommended during initial urological evaluation of patients with relevant neurological conditions, even without symptoms, according to the American Urological Association 6, 5
Intermittent catheterization is strongly preferred over indwelling catheters for bladder emptying in NLUTD patients, as stated by the European Association of Urology 1, 2
Urotherapy aimed at optimizing bladder emptying efficiency may include regular moderate drinking and voiding regimen 4, proper voiding posture 4, and double voiding technique 2

Overflow incontinence occurs when the bladder fills beyond capacity and urine leaks passively due to mechanical overflow rather than active detrusor contraction in patients after extensive pelvic surgery 8, 9
Elevated post-void residual volumes are characteristic, as the bladder fails to empty completely in patients with neurogenic bladder after pelvic surgery 10

The American Urological Association (AUA) and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) guidelines recommend post-void residual assessment in patients with conditions like radical pelvic surgery 10
Intermittent catheterization becomes the primary management strategy for patients with neurogenic bladder after extensive pelvic surgery, as they develop incomplete bladder emptying with overflow incontinence 8, 9
Indwelling catheters should be avoided except as a last resort due to high risks of infection, urethral erosion, and stone formation in patients with neurogenic bladder after pelvic surgery 8, 9

Spinal cord injury is a major cause of neurogenic bladder, with nearly all patients developing some degree of bladder dysfunction, according to the American College of Radiology 11
Spina bifida (myelomeningocele) causes developmental abnormalities of spinal cord innervation, with approximately 26% of these patients developing renal failure, as reported by the American College of Radiology and the American Urological Association 11, 12
Diabetes mellitus causes peripheral neuropathy affecting bladder innervation, as stated by the American Diabetes Association 13, 12
Chronic alcohol use may cause neuropathy affecting bladder function, according to the American Urological Association 12
AIDS can result in neurological complications affecting voiding, as reported by the American Urological Association 12

Initial evaluation may not predict long-term dysfunction in patients with neurogenic bladder, and risk stratification must be repeated when patients experience new or worsening symptoms, as recommended by the American Urological Association 14, 11
Regular monitoring is essential even in asymptomatic patients with relevant neurological conditions, according to the American Urological Association 12
The American Urological Association recommends that neurogenic bladder be treated as a manifestation of nervous system pathology that requires ongoing neurological and urological assessment 14

The American Urological Association recommends that neurogenic bladder can manifest as detrusor overactivity (most common at 48%), impaired contractility (30%), or poor compliance (15%) 15
In diabetic neurogenic bladder, impaired bladder sensation, increased cystometric capacity, decreased detrusor contractility, and increased post-void residual are common findings 15, 16
Complete urodynamic testing, including cystometry, uroflow, pressure/flow studies, and sphincter electromyography, is recommended for neurogenic bladder diagnosis 15, 16
Electrophysiological testing for peripheral neuropathy assessment is also recommended for neurogenic bladder diagnosis 15, 16

Detrusor overactivity is the most common urodynamic finding in neurogenic bladder (48%), not underactivity 15
Neurogenic bladder encompasses a spectrum of dysfunction, including overactivity, underactivity, and compliance issues, all unified by their neurological etiology 15, 16